Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in alzheimer's disease

Brain Pathology

Volumn 19, Issue 3, 2009, Pages 392-398

  Sokolova, Anna ^a   Hill, Michelle D ^a   Rahimi, Farid ^a   Warden, Lolita A ^a   Halliday, Glenda M ^a   Shepherd, Claire E ^a  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Alzheimer's Disease; Inflammation; Monocyte Chemotactic Protein 1

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN ATROPHY; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASTROCYTES; BRAIN; CHEMOKINE CCL2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NEURONS; SENILE PLAQUES;

EID: 66949146836     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2008.00188.x     Document Type: Article

References (52)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G et al (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21 : 383 421. (Pubitemid 30349107)
2. Araujo D, Lapchak P (1994) Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors. Neuroscience 61 : 745 754. (Pubitemid 24291917)
3. Bauer J, Strauss S, Schreiter-Gasser U, Ganter U, Schlegel P, Witt I et al (1991) Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett 285 : 111 114.
4. Brodmerkel C, Huber R, Covington M, Diamond S, Hall L, Collins R et al (2005) Discovery and pharmacological characterisation of a novel rodent-active CCR2 antagonist - INCB3344. J Immunol 175 : 5370 5378. (Pubitemid 41456423)
5. Cacabelos R, Alvarez X, Fernandez-Novoa L, Franco A, Mangues R, Pellicer A, Nishimura T (1994) Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. Methods Find Exp Clin Pharmacol 16 : 141 151.
6. Cagnin A, Gerhard A, Banati R (2002) In vivo imaging of neuroinflammation. Eur Neuropsychopharmacol 12 : 581 586. (Pubitemid 35408707)
7. de Haas A, van Weering H, de Jong E, Boddeke H, Biber K (2007) Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol 36 : 137 151. (Pubitemid 351360343)
8. Dickson DW, Lee SC, Mattiace LA, Yen S-HC, Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7 : 75 83.
9. El Khoury J, Toft M, Hickman S, Means T, Terada K, Geula C, Luster A (2007) CCR2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13 : 432 438. (Pubitemid 46559828)
10. Ferreira A, Rollins B, Faunce D, Burns A, Zhu X, DiPietro L (2005) The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network of acute inflammation. Cytokine 30 : 64 71. (Pubitemid 40432631)
11. Galimberti D, Fenoglio C, Lovati C, Venturelli E, Guidi I, Corra B et al (2006) Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease. Neurobiol Ageing 27 : 1763 1768. (Pubitemid 44572579)
12. Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E et al (2006) Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63 : 538 543.
13. Gomez-Isla T, Growdon W, McNamara M, Nochlin D, Bird T, Arango J et al (1999) The impact of different presenilin 1 and presenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain. Evidence for other phenotype-modifying factors. Brain 122 : 1709 1719. (Pubitemid 29425674)
14. Grammas P, Ovase R (2001) Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging 22 : 837 842. (Pubitemid 34066550)
15. Gregory G, Macdonald V, Schofield P, Kril J, Halliday G (2006) Differences in regional brain atrophy in genetic forms of Alzheimer's disease. Neurobiol Aging 27 : 387 393. (Pubitemid 43186040)
16. Griffin W (2006) Inflammation and neurodegenerative diseases. Am J Clin Nutr 83 : 470S 474S. (Pubitemid 44713221)
17. Griffin W, Stanley L, Ling C, White L, MacLeod V, Perrot L et al (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86 : 7611 7615. (Pubitemid 19254506)
18. Henkel J, Beers D, Siklos L, Appel S (2006) The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci 31 : 427 437. (Pubitemid 43358017)
19. Ho G, Drego R, Hakimian E, Masliah E (2005) Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy 4 : 247 256. (Pubitemid 40873107)
20. Huell M, Strauss S, Volk B, Berger M, Bauer J (1995) Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol 89 : 544 551.
21. Hulse R, Kunkler P, Fedynyshyn J, Kraig R (2004) Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue. J Neurosci Methods 136 : 87 98. (Pubitemid 38569875)
22. Ishizuka K, Kimura T, Igata-yi R, Katsuragi S, Takamatsu J, Miyakawa T (1997) Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 51 : 135 138. (Pubitemid 27262094)
23. Janelsins M, Mastrangelo M, Oddo S, LaFerla F, Federoff H, Bowers W (2005) Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2 : 23.
24. Kwok J, Taddei K, Hallupp M, Fisher C, Brooks W, Broe G et al (1997) Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport 8 : 1537 1542. (Pubitemid 27242571)
25. Lanzrein A, Johnston C, Perry V, Jobst K, King E, Smith A (1998) Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis Assoc Disord 12 : 215 227. (Pubitemid 29154993)
26. Loring J, Wen X, Lee J, Seilhamer J, Somogyi R (2001) A gene expression profile of Alzheimer's disease. DNA Cell Biol 20 : 683 695. (Pubitemid 34072835)
27. Lue L, Rydel R, Brigham E, Yang L, Hampel H, Murphy G et al (2001) Inflammatory repetoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35 : 72 79. (Pubitemid 32656755)
28. Luterman J, Haroutunian V, Yemul S, Ho L, Purohit D, Aisen P et al (2000) Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol 57 : 1153 1160. (Pubitemid 30644662)
29. Matsui M, Weaver J, Proudfoot A, Wujek J, Wei T, Richer E et al (2002) Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist met-RANTES. J Neuroimmunol 128 : 16 33.
30. Miguel-Hidalgo J, Nithuairisg S, Stockmeier C, Rajkowska G (2007) Distribution of ICAM-1 immunoreactivity during aging in the human orbitofrontal cortex. Brain Behav Immun 21 : 100 111. (Pubitemid 44869008)
31. Mulugeta E, Molina-Holgado F, Elliott M, Hortobayagi T, Perry R, Kalaria R et al (2007) Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia. Dement Geriatr Cogn Disord 25 : 278 286.
32. Parachikova A, Agadjanyan M, Cribbs D, Blurton-Jones M, Perreau V, Rogers J et al (2006) Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Ageing 28 : 1821 1833.
33. Pulliam L, Sun B, Rempel H (2004) Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J Neuroimmunol 157 : 93 98. (Pubitemid 39576642)
34. Sastre M, Klockgether T, Heneka M (2006) Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int J Dev Neurosci 24 : 167 176. (Pubitemid 43294623)
35. Sheng J, Mrak R, Rovanghi C, Kozlowska E, Van Eldik L, Griffin W (1996) Human brain S100B and S100B mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol Aging 17 : 359 363. (Pubitemid 26200412)
36. Shepherd C, McCann H, Thiel E, Halliday G (2002) Neurofilament- immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies. Neurobiol Dis 9 : 249 257. (Pubitemid 34261219)
37. Shepherd C, Gregory G, Vickers J, Brooks W, Kwok J, Schofield P et al (2004) Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques. Neurobiol Dis 15 : 115 119. (Pubitemid 38134386)
38. Shepherd C, Gregory G, Vickers J, Halliday G (2005) Novel inflammatory plaque pathology in presenilin 1 Alzheimer's disease. Neuropathol Appl Neurobiol 31 : 503 511. (Pubitemid 41337784)
39. Shepherd C, Grace E, Mann D, Halliday G (2007) Relationship between neuronal loss and "inflammatory plaques" in early onset Alzheimer's disease. Neuropathol Appl Neurobiol 33 : 328 333. (Pubitemid 46701047)
40. Shepherd CE, Thiel E, McCann H, Harding TJ, Halliday GM (2000) Cortical inflammation in Alzheimer's disease but not dementia with Lewy bodies. Arch Neurol 57 : 817 822. (Pubitemid 30397183)
41. Simard A, Soulet D, Gowing G, Julien J, Rivest S (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 : 489 502. (Pubitemid 43221886)
42. Szczepanik A, Rampe D, Ringheim G (2001) Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo. J Neurochem 77 : 304 317. (Pubitemid 32245104)
43. Tanuma N, Sakuma H, Sasaki A, Matsumoto Y (2006) Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol 112 : 195 204.
44. Ubogu E, Cossoy M, Ranshoff R (2006) The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci 27 : 48 54.
45. Walker D, Lue L, Beach T (2001) Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol Aging 22 : 957 966. (Pubitemid 34066564)
46. Wang G, Zhang Y, Chen B, Cheng J (2003) Preliminary studies on Alzheimer's disease using cDNA microarrays. Mech Ageing Dev 124 : 115 124. (Pubitemid 36266684)
47. Weeraratna A, Kalehua A, DeLeon I, Bertak D, Maher G, Wade M et al (2007) Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. Exp Cell Res 313 : 450 461. (Pubitemid 46186300)
48. Wood J, Wood P, Ryan R, Graff-Radford N, Pilapil C, Robitaille Y, Quirion R (1993) Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res 629 : 245 252. (Pubitemid 23337798)
49. Xia M, Qin S, McNamara M, Mackay C, Hyman BT (1997) Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am J Pathol 150 : 1267 1274. (Pubitemid 27152645)
50. Xia M, Qin S, Wu L, Mackay C, Hyman B (1998) Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am J Pathol 153 : 31 37. (Pubitemid 28317504)
51. Yamamoto M, Horiba M, Buescher J, Huang D, Gendelman H, Ranshoff R, Ikezu T (2005) Overexpression of monocyte chemotactic protein - 1/CCL2 in B-amyloid precursor protein transgenic mice show accelerated diffuse B-amyloid deposition. Am J Pathol 166 : 1475 1485. (Pubitemid 40586517)
52. Zhao M, Cribbs D, Anderson A, Cummings B, Su J, Wasserman A, Cotman C (2003) The induction of the TNF-alpha death domain signaling pathway in Alzheimer's disease brain. Neurochem Res 28 : 307 318. (Pubitemid 36207354)